CS236876B2 - Processing of new dibenzoxazine - Google Patents

Processing of new dibenzoxazine Download PDF

Info

Publication number
CS236876B2
CS236876B2 CS833145A CS314583A CS236876B2 CS 236876 B2 CS236876 B2 CS 236876B2 CS 833145 A CS833145 A CS 833145A CS 314583 A CS314583 A CS 314583A CS 236876 B2 CS236876 B2 CS 236876B2
Authority
CS
Czechoslovakia
Prior art keywords
benzoxazin
butoxy
dimethyl
melting point
group
Prior art date
Application number
CS833145A
Other languages
Czech (cs)
English (en)
Inventor
Berthold Narr
Josef Nickl
Erich Mueller
Josef Roch
Walter Haarmann
Johannes-Maximili Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of CS236876B2 publication Critical patent/CS236876B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
CS833145A 1982-05-06 1983-05-04 Processing of new dibenzoxazine CS236876B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823217012 DE3217012A1 (de) 1982-05-06 1982-05-06 Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
CS236876B2 true CS236876B2 (en) 1985-05-15

Family

ID=6162917

Family Applications (1)

Application Number Title Priority Date Filing Date
CS833145A CS236876B2 (en) 1982-05-06 1983-05-04 Processing of new dibenzoxazine

Country Status (25)

Country Link
US (1) US4518597A (xx)
EP (1) EP0093922B1 (xx)
JP (1) JPS58203979A (xx)
KR (1) KR900006546B1 (xx)
AT (1) ATE24501T1 (xx)
AU (1) AU563453B2 (xx)
CA (1) CA1204744A (xx)
CS (1) CS236876B2 (xx)
DD (1) DD210453A5 (xx)
DE (2) DE3217012A1 (xx)
DK (1) DK164860C (xx)
ES (3) ES8402585A1 (xx)
FI (1) FI79704C (xx)
GB (1) GB2119382B (xx)
GR (1) GR79255B (xx)
HU (1) HU194842B (xx)
IE (1) IE55481B1 (xx)
IL (1) IL68573A (xx)
NO (1) NO158738C (xx)
NZ (1) NZ204143A (xx)
PL (1) PL139119B1 (xx)
PT (1) PT76627B (xx)
SU (1) SU1138025A3 (xx)
YU (1) YU42854B (xx)
ZA (1) ZA833190B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3439281A1 (de) * 1984-10-26 1986-04-30 Bayer Ag, 5090 Leverkusen Chromogene 4,4-diaryl-2-oxo-benzo-3,1-oxazine, ihre herstellung und verwendung
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP2247579B1 (en) * 2008-01-17 2012-04-18 Bayer Pharma Aktiengesellschaft Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
US9834525B2 (en) 2014-02-04 2017-12-05 University Of Tennessee Research Foundation Inhibitors of paxillin function and related compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3542774A (en) * 1968-07-05 1970-11-24 Warner Lambert Pharmaceutical 3,4-dihydrobenzoxazinones
CH624395A5 (xx) * 1976-01-08 1981-07-31 Ciba Geigy Ag
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2

Also Published As

Publication number Publication date
ES526724A0 (es) 1984-07-01
EP0093922A2 (de) 1983-11-16
GB8312344D0 (en) 1983-06-08
KR840004736A (ko) 1984-10-24
IE55481B1 (en) 1990-09-26
NO831599L (no) 1983-11-07
YU95783A (en) 1985-10-31
ATE24501T1 (de) 1987-01-15
DK164860C (da) 1993-01-11
JPS58203979A (ja) 1983-11-28
PT76627A (de) 1983-06-01
ES522104A0 (es) 1984-02-01
PT76627B (de) 1986-02-26
GR79255B (xx) 1984-10-22
ES8406454A1 (es) 1984-07-01
DD210453A5 (de) 1984-06-13
CA1204744A (en) 1986-05-20
FI831412A0 (fi) 1983-04-26
IE831032L (en) 1983-11-06
NO158738B (no) 1988-07-18
DK195583A (da) 1983-11-07
KR900006546B1 (ko) 1990-09-13
US4518597A (en) 1985-05-21
AU1426583A (en) 1983-11-10
NZ204143A (en) 1986-02-21
ES8406453A1 (es) 1984-07-01
AU563453B2 (en) 1987-07-09
GB2119382A (en) 1983-11-16
DE3217012A1 (de) 1983-11-10
SU1138025A3 (ru) 1985-01-30
YU42854B (en) 1988-12-31
DE3368621D1 (en) 1987-02-05
IL68573A0 (en) 1983-09-30
NO158738C (no) 1988-11-16
ES526723A0 (es) 1984-07-01
FI831412L (fi) 1983-11-07
EP0093922B1 (de) 1986-12-30
ES8402585A1 (es) 1984-02-01
ZA833190B (en) 1985-01-30
GB2119382B (en) 1985-09-18
DK195583D0 (da) 1983-05-03
PL241806A1 (en) 1984-08-13
FI79704C (fi) 1990-02-12
IL68573A (en) 1986-10-31
HU194842B (en) 1988-03-28
FI79704B (fi) 1989-10-31
EP0093922A3 (en) 1984-01-25
PL139119B1 (en) 1986-12-31
DK164860B (da) 1992-08-31

Similar Documents

Publication Publication Date Title
US5104890A (en) Benzopyran derivatives and processes for preparation thereof
EP0354994B1 (en) Quinoline derivatives, their production and use
US4711888A (en) Hydroxy and alkoxy pyrimidines
US4698344A (en) 1-Heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments
HU207999B (en) Process for producing quinazolin-3-alkanoic acids and pharmaceutical compositions containing them
US4302460A (en) 4-Quinolinones having antihypertensive activity
EP1879866B1 (en) Dihydropyridine derivatives
CS236876B2 (en) Processing of new dibenzoxazine
JPH0225464A (ja) 二環式カルボキサミド、これを含有する、赤血球凝集または血小板凝集阻止作用を有する医薬、および該化合物製造の中間生成物
US4767766A (en) Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
NO164351B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
US4636497A (en) Anti-thrombotic pharmaceutical compositions comprising tricyclo-4H-1,4-benzothiazine derivatives and method of use therefor
US5405848A (en) Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US5006532A (en) Derivatives of 3-hydroxyazabenzo(beta)thiophene useful as 5-lipoxygenase inhibitors
KR100497896B1 (ko) 플라본유도체및이를함유하는의약
FI69064B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla karbostyril- och oxindolderivat
US4942245A (en) Benzimidazole Derivatives
JPH037259A (ja) Ａｃａｔ阻害剤、キノリン誘導体及びその製造法
GB2047691A (en) Therapeutic agents
CZ20023141A3 (cs) 4-Oxo-1,4-dihydro-3-cinnolinkarboxamidy jako antivirové látky
SU1158041A3 (ru) Способ получени производных сульфимина
PL81112B1 (en) Sulphonyl-ureas [gb1313539a]